<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OALibJ</journal-id><journal-title-group><journal-title>Open Access Library Journal</journal-title></journal-title-group><issn pub-type="epub">2333-9705</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/oalib.1108144</article-id><article-id pub-id-type="publisher-id">OALibJ-113426</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Business&amp;Economics</subject><subject> Chemistry&amp;Materials Science</subject><subject> Computer Science&amp;Communications</subject><subject> Earth&amp;Environmental Sciences</subject><subject> Engineering</subject><subject> Medicine&amp;Healthcare</subject><subject> Physics&amp;Mathematics</subject><subject> Social Sciences&amp;Humanities</subject></subj-group></article-categories><title-group><article-title>
 
 
  Management of Intramedullary Spinal Cord Tumors with 26 Cases in the Department of Neurosurgery of Ibn Sina University Hospital—Rabat
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zakaria</surname><given-names>Chandide Tlemcani</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mustapha</surname><given-names>Hemama</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nizar</surname><given-names>El Fatemi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Neurosurgery, Hospital of IBN SINA, Faculty of Medicine and pharmacy of Rabat, Mohamed V University, Rabat, Morocco</addr-line></aff><pub-date pub-type="epub"><day>27</day><month>10</month><year>2021</year></pub-date><volume>08</volume><issue>11</issue><fpage>1</fpage><lpage>10</lpage><history><date date-type="received"><day>2,</day>	<month>November</month>	<year>2021</year></date><date date-type="rev-recd"><day>23,</day>	<month>November</month>	<year>2021</year>	</date><date date-type="accepted"><day>26,</day>	<month>November</month>	<year>2021</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Intramedullary spinal cord tumors are relatively rare neoplasms of all Central Nervous System (CNS) tumors. Their treatment and prognosis are largely dependent on tumor histology and patient functionality. The introduction and breakthroughs of microsurgical techniques have made surgery the mainstay of treatment for intramedullary tumors. We performed a retrospective analysis of 26 cases of primitive intramedullary spinal cord tumors treated between 2013 and 2019 at the Neurosurgery Department of Ibn SINA University Hospital of Rabat. In our patient’s population, the sex ratio was 1.75 showing with a predominance of male over female patients. The median age was 26 years old. The clinical symptomatology is dominated by a slow medullar compression. Spinal magnetic resonance imaging (MRI) was performed for all the patients and led to the positive diagnosis in all cases with a radio-histological correlation in 54.4% of the cases. The treatment was surgical in all cases by laminectomy in posterior access. This surgery has allowed a complete tumoral resection. Histological examination of the tumor was done for all patients and led to diagnosis confirmation in all cases. Understanding intramedullary spinal tumor is imperative to design proper management and obtain optimal patient outcomes. In addition, a meticulous operative technique and the use of surgical adjuncts are essential to accomplish proper tumor removal, diminish the risk of recurrence, and preserve neurologic functions.
 
</p></abstract><kwd-group><kwd>Intramedullary Spinal Cord Tumor</kwd><kwd> Complete Removal</kwd><kwd> Microsurgical Technique</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Intramedullary spinal cord tumors are rare primary spine neoplasms of the CNS. It accounts for 2% - 5% of CNS neoplasms in adults and it remains a clinical challenge due to potential delay in diagnosis and limited therapeutic options [<xref ref-type="bibr" rid="scirp.113426-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.113426-ref2">2</xref>] .</p><p>The most common types are Ependymomas, Astroctyomas, Hemangioblastoma [<xref ref-type="bibr" rid="scirp.113426-ref2">2</xref>] . These lesions have their own hallmark characteristics; however, they remain both radiographically and clinically difficult to distinguish from one another. The Surgical resection remains the mainstay of treatment of this tumor.</p><p>The purpose of this work is to assess the service experience in terms of care of this pathology, and to compare our results with those of the literature.</p></sec><sec id="s2"><title>2. Material and Methods</title><p>This is a Retrospective analysis of 26 cases of Primitive Intramedullary Spinal Cord Tumors treated between 2013 and 2019 at the Neurosurgery Department of Ibn SINA University Hospital of Rabat.</p><p>Different parameters were used from the medical records from our neurosurgery department. A pre-established operating sheet produced for this purpose enabled the collection of epidemiological, clinical, para-clinical, therapeutic and evolutionary data. These parameters are then collected and analyzed.</p></sec><sec id="s3"><title>3. Results</title><p>During 7 years, we admitted 26 cases of intramedullary spinal cord tumors to our department.</p><sec id="s3_1"><title>3.1. Age Repartition</title><p>The age distribution of our cases varies from 18 to 74 years.</p></sec><sec id="s3_2"><title>3.2. Sex Ratio</title><p>In our series, we had 10 female and 16 male (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p></sec><sec id="s3_3"><title>3.3. Consultation Deadline</title><p>It is defined by the time elapsed between the first clinical sign and the diagnosis. It varied between 4 months and 6 years, with an average of 21 months.</p></sec><sec id="s3_4"><title>3.4. Clinical Exam</title><p>We find 24 cases (92.30%) of Motor disorder, 19 cases (73.07%) of sensitive</p><p>disorder, 11 cases of radicular pain (42.3%) and 10 cases of sphincter disorder (38.46%). We resumed this clinical finding into FRANKEL rating (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s3_5"><title>3.5. Imaging Finding</title><p>T1 and T2-weighted MRI with gadolinium enhancement is the imaging modality of choice for suspected Intramedullary Spinal Cord Tumor.</p><p>We had 11 cases of cervical localization (42.30%), 05 cases of cervico dorsal tumors, 06 cases of dorsal tumors (23.07%) and only 4 cases of Lumbar tumors (15.38%).</p><p>MRI finding was useful to characterize some tumors (Figures 2-5).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Neurological status according to the FRANKEL rating</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >FRANKEL</th><th align="center" valign="middle" >NUMBER OF CASES</th><th align="center" valign="middle" >PERCENTAGE</th></tr></thead><tr><td align="center" valign="middle" >A: complete motor an sensory loss</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >19.23%</td></tr><tr><td align="center" valign="middle" >B: complete motor loss, incomplete sensory loss</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >34.61%</td></tr><tr><td align="center" valign="middle" >C: incomplete motor loss without practical use</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >26.92%</td></tr><tr><td align="center" valign="middle" >D: incomplete motor loss, able to ambulate with or without walking aids</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >11.53%</td></tr><tr><td align="center" valign="middle" >E: free of neurological symptoms</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >7.69%</td></tr></tbody></table></table-wrap></sec><sec id="s3_6"><title>3.6. Surgery</title><p>The objectives of the surgery were to perform decompression by laminectomy, to do a complete resection as possible and to confirm the diagnosis by taking a sample for histological studies.</p><p>The surgical approach of intramedullary tumors was performed under an operative microscope in all cases (100%), and tumor resection was complete in 15 cases (57.69%) and incomplete in 10 cases (38.46%)</p><p>Some microscopic operative image of our spinal cord tumors (<xref ref-type="fig" rid="fig6">Figure 6</xref>, <xref ref-type="fig" rid="fig7">Figure 7</xref>).</p></sec><sec id="s3_7"><title>3.7. Anatomopatholog</title><p>The histologic study was essential to confirm the diagnosis of intramedullary tumors.</p><p>We note in our series a predominance of astrocytomas, representing 38.46% of cases (<xref ref-type="table" rid="table2">Table 2</xref>).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of histological diagnoses</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >TUMOR TYPE</th><th align="center" valign="middle" >NUMBER OF CASES</th><th align="center" valign="middle" >PERCENTAGE</th></tr></thead><tr><td align="center" valign="middle" >Astrocytoma</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >38.46%</td></tr><tr><td align="center" valign="middle" >Ependymoma</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >30.76%</td></tr><tr><td align="center" valign="middle" >Hemagioblastoma</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >7.69%</td></tr><tr><td align="center" valign="middle" >Dermoid cyct</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >11.53%</td></tr><tr><td align="center" valign="middle" >Epidermoid cyst</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >7.69%</td></tr><tr><td align="center" valign="middle" >Oligodendroglioma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.84%</td></tr></tbody></table></table-wrap></sec><sec id="s3_8"><title>3.8. Evolution</title><p>In our series, there were no cases of death and by comparing the neurological states in the immediate pre and postoperative period, we noted Improvement in 15 cases (57.69%), worsening in 6 cases (23.07%), and a steady state in 5 cases (19.23%).</p><p>The postoperative consequences were simple, except for one case of meningitis on 6st day postoperative, which has progressed well under antibiotic treatment.</p></sec></sec><sec id="s4"><title>4. Discussion</title><sec id="s4_1"><title>4.1. Epidemiology</title><p>The average age of discovery of intramedullary spinal cord tumors in the literature varies between 28 and 44 years, with a maximum frequency noted in the third decade of life (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>Most of the series report a slight predominance of the occurrence of intramedullary spinal cord tumors in male sex.</p><p>The time taken to diagnose intramedullary tumors varies from one series to another, in the CHANDY series [<xref ref-type="bibr" rid="scirp.113426-ref6">6</xref>] , this time varied from 3 weeks to 15 years, in our series this diagnostic timeframe varied from 4 months to 6 years with a 21-month average (<xref ref-type="table" rid="table4">Table 4</xref>).</p><p>For each tumor considered, the duration of development differs according to the grade histological.</p><p>According to the literature, hemangiomas have an average duration of evolution before the diagnosis of a year and a half.</p></sec><sec id="s4_2"><title>4.2. Clinical Finding</title><p>Spinal pain was only revealing in 42.3% of cases in our series, while in the literature we find higher percentages. In our series, motor disorders are reported in almost all cases (92.3%) (<xref ref-type="table" rid="table5">Table 5</xref>). On the other hand, sphincter dysfunctions tend to appear late in the course of the disease, and are initially limited to incontinence or urinary retention. In our series, they were revealing in 38.46% of cases. In the FADI series [<xref ref-type="bibr" rid="scirp.113426-ref7">7</xref>] , these disorders were initial in 35%.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution according to the mean age of onset in the literature</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Series</th><th align="center" valign="middle" >Number of cases</th><th align="center" valign="middle" >Average age</th></tr></thead><tr><td align="center" valign="middle" >KELLY [<xref ref-type="bibr" rid="scirp.113426-ref3">3</xref>]</td><td align="center" valign="middle" >183</td><td align="center" valign="middle" >38.8</td></tr><tr><td align="center" valign="middle" >DAVID [<xref ref-type="bibr" rid="scirp.113426-ref4">4</xref>]</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" >28.5</td></tr><tr><td align="center" valign="middle" >OLIVER [<xref ref-type="bibr" rid="scirp.113426-ref5">5</xref>]</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >41</td></tr><tr><td align="center" valign="middle" >OUR SERIE</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >36.43</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Time to progression of intramedullary tumors in the literature/our series</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Series</th><th align="center" valign="middle" >Number of cases</th><th align="center" valign="middle" >Diagnostic delay (months)</th></tr></thead><tr><td align="center" valign="middle" >KELLY</td><td align="center" valign="middle" >183</td><td align="center" valign="middle" >36.5</td></tr><tr><td align="center" valign="middle" >DAVID</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" >36</td></tr><tr><td align="center" valign="middle" >CHANDY [<xref ref-type="bibr" rid="scirp.113426-ref6">6</xref>]</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >31.2</td></tr><tr><td align="center" valign="middle" >OUR SERIE</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >21</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Comparison of the clinical results of our series with the literature</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >SPINAL PAIN</th><th align="center" valign="middle" >MOTOR DISORDER</th><th align="center" valign="middle" >SENTIF DISORDER</th><th align="center" valign="middle" >SPHINCTER DYSFONCTION</th></tr></thead><tr><td align="center" valign="middle" >KELLY</td><td align="center" valign="middle" >122/183 67%</td><td align="center" valign="middle" >158/183 86.6%</td><td align="center" valign="middle" >79/183 43%</td><td align="center" valign="middle" >61/183 33%</td></tr><tr><td align="center" valign="middle" >FADI [<xref ref-type="bibr" rid="scirp.113426-ref7">7</xref>]</td><td align="center" valign="middle" >17/26 65%</td><td align="center" valign="middle" >18/26 69%</td><td align="center" valign="middle" >15/26 57.69%</td><td align="center" valign="middle" >9/26 35%</td></tr><tr><td align="center" valign="middle" >OLIVER</td><td align="center" valign="middle" >23/27 85%</td><td align="center" valign="middle" >20/27 76%</td><td align="center" valign="middle" >14/27 51.85%</td><td align="center" valign="middle" >3/27 11%</td></tr><tr><td align="center" valign="middle" >OUR SERIE</td><td align="center" valign="middle" >11/26 42.3%</td><td align="center" valign="middle" >24/26 92.30%</td><td align="center" valign="middle" >19/26 73.07%</td><td align="center" valign="middle" >10/26 38.46%</td></tr></tbody></table></table-wrap><p>These data are consistent with the results of our series, where the cervical was the most affected 42.30%, then the thoracic level (23.07%) (<xref ref-type="table" rid="table6">Table 6</xref>).</p></sec><sec id="s4_3"><title>4.3. Surgery</title><p>The difficulty lies in the fact that only a radical excision can prevent recurrence, we must then find the right compromise between a maximum excision with minimal functional risk.</p><p>In our series, complete tumor resection (macroscopically) was performed in 15 patients (57.69%) and incomplete in 10 patients (38.46%) (<xref ref-type="table" rid="table7">Table 7</xref>).</p><p>Adjuvant radiotherapy is advocated when resection is contraindicated or if the tumor is high grade. The role of radiotherapy is controversial, however. Some studies suggest a positive outcome whilst others suggest no benefit [<xref ref-type="bibr" rid="scirp.113426-ref8">8</xref>] . In addition, several side effects are associated with radiotherapy such as radiation myelopathy and spinal deformities [<xref ref-type="bibr" rid="scirp.113426-ref9">9</xref>] . Chemotherapy also seems to have limited role and is generally used only when resection and adjuvant radiotherapy were unsuccessful.</p><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Topographic distribution of intramedullary tumors</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >CERVICAL</th><th align="center" valign="middle" >CERVICO DORSAL</th><th align="center" valign="middle" >DORSAL</th><th align="center" valign="middle" >LUMBAR</th></tr></thead><tr><td align="center" valign="middle" >SUN [<xref ref-type="bibr" rid="scirp.113426-ref8">8</xref>]</td><td align="center" valign="middle"  colspan="2"  >30/56 53.57%</td><td align="center" valign="middle" >9/56 16.07%</td><td align="center" valign="middle" >17/56 30.35%</td></tr><tr><td align="center" valign="middle" >BERHOUMA [<xref ref-type="bibr" rid="scirp.113426-ref9">9</xref>]</td><td align="center" valign="middle" >20/45 44.44%</td><td align="center" valign="middle" >5/45 11.11%</td><td align="center" valign="middle" >15/45 33.33%</td><td align="center" valign="middle" >5/45 11.11%</td></tr><tr><td align="center" valign="middle" >OUR SERIE</td><td align="center" valign="middle" >11/26 cases 42.30%</td><td align="center" valign="middle" >5/26 cases 19.23%</td><td align="center" valign="middle" >6/26 cases 23.7%</td><td align="center" valign="middle" >4/26 cases 15.38%</td></tr></tbody></table></table-wrap><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Extent of surgical excision in the literature</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >COMPLETE RESECTION</th><th align="center" valign="middle" >INCOMPLETE RESECTION</th><th align="center" valign="middle" >BIOPSIE</th></tr></thead><tr><td align="center" valign="middle" >SUN</td><td align="center" valign="middle" >33/56 cases 58%</td><td align="center" valign="middle" >20/56 cases 35%</td><td align="center" valign="middle" >3 cases 7%</td></tr><tr><td align="center" valign="middle" >BERHOUMA</td><td align="center" valign="middle" >31/45 69%</td><td align="center" valign="middle" >11/45 24.4%</td><td align="center" valign="middle" >3/45 6.6%</td></tr><tr><td align="center" valign="middle" >SANDALCIOGLU [<xref ref-type="bibr" rid="scirp.113426-ref10">10</xref>]</td><td align="center" valign="middle" >65/78 83.3%</td><td align="center" valign="middle" >9/78 11.5%</td><td align="center" valign="middle" >4/78 5%</td></tr><tr><td align="center" valign="middle" >OUR SERIE</td><td align="center" valign="middle" >15/26 cases 57.69%</td><td align="center" valign="middle" >10/26 cases 38.46%</td><td align="center" valign="middle" >1 case 3.84%</td></tr></tbody></table></table-wrap></sec><sec id="s4_4"><title>4.4. Histological Results</title><p>The majority of authors report that the degree of tumor excision depends mainly to the type and histological grade of the tumor. In most of the published series, we note the predominance of ependymomas [<xref ref-type="bibr" rid="scirp.113426-ref10">10</xref>] .</p><p>In our series, astrocytomas accounted for 38.46% of cases, against 30.76% of ependymoma.</p><p>The ependymoma is most often well defined and with patience, we can discover the cleavage plane that will allow the tumor to be removed as completely as possible.</p><p>The complete excision of an infiltrating tumor such as astrocytoma, has been greatly facilitated by the use of the ultrasonic scalpel CAVITRON.</p></sec><sec id="s4_5"><title>4.5. Recurrence</title><p>For ependymomas, recurrence after complete resection is rare, with a rate not exceeding 5%, but they can manifest after several years. In most series, the operative mortality rate is zero [<xref ref-type="bibr" rid="scirp.113426-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.113426-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.113426-ref11">11</xref>] , this is also the case in our series.</p><p>Regular MRI is recommended every 1 - 2 years, and any possible recurrence will be best dealt with a new surgical resection.</p><p>Since astrocytomas are infiltrating lesions, their removal often leaves persistent tumor cells, which explains the high rate of local recurrence.</p><p>So, the total resection allow a good clinical improvement, and prevent long-term recurrence and decrease the morbidity, even if sometimes a subtotal resection with radiotherapy may preserve a stable neurological status, and good local control of the lesions.</p></sec><sec id="s4_6"><title>4.6. Prognosis</title><p>The factors positively influencing the prognosis are early Diagnosis and rapid management with a good preoperative neurological status, and rate tumor width/Medullary width &lt;0.80.</p><p>Low histological grade of the tumor is also essential prognosis factors with an extent radical surgery.</p></sec></sec><sec id="s5"><title>5. Conclusion</title><p>Understanding intramedullary spinal tumor is imperative to design proper management and obtain optimal patient outcomes. In addition, a meticulous operative technique and the use of surgical adjuncts are essential to accomplish proper tumor removal, in order to diminish the risk of recurrence, and preserve neurologic functions.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec id="s7"><title>Cite this paper</title><p>Tlemcani, Z.C., Hemama, M. and El Fatemi, N. (2021) Management of Intramedullary Spinal Cord Tumors with 26 Cases in the Department of Neurosurgery of Ibn Sina University Hospital―Rabat. Open Access Library Journal, 8: e8144. https://doi.org/10.4236/oalib.1108144</p></sec></body><back><ref-list><title>References</title><ref id="scirp.113426-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Clemenceau, S. and Lopez, M. (2000) Tumeurs Intramédullaires. Revue du Praticien, 50, 226.</mixed-citation></ref><ref id="scirp.113426-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Schellinger, K.A., Propp, J.M., Villano, J.L. and Mccarthy, B.J. (2008) Descriptive Epidemiology of Primary Spinal Cord Tumors. Journal of Neuro-Oncology, 87, 173- 179. https://doi.org/10.1007/s11060-007-9507-z</mixed-citation></ref><ref id="scirp.113426-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Koeller</surname><given-names> K.K. and Rosenblum</given-names></name>,<name name-style="western"><surname> R.S. and Morrison</surname><given-names> A.L. </given-names></name>,<etal>et al</etal>. (<year>2000</year>)<article-title>Neoplasms of the Spinal Cord and Filum Terminal: Radiologic-Pathologic Correlation</article-title><source> Radiographics</source><volume> 20</volume>,<fpage> 1721</fpage>-<lpage>1749</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.113426-ref4"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Horth</surname><given-names> D.P. </given-names></name>,<etal>et al</etal>. (<year>2002</year>)<article-title>Astrocytomes Intramédullaires: Conduite à Tenir</article-title><source> La lettre de neurologie</source><volume> 5</volume>,<fpage> 165</fpage>-<lpage>167</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.113426-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Hausmann, O.N., Kirsch, E.C., Tolnay, M. and Gratzl, O. (2001) Intramedullary Spinal Cord Tumors: A Clinical Outcome and Radiological Follow up Study. Swiss Medical Weekly, 131, 582-587.</mixed-citation></ref><ref id="scirp.113426-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Chandy, M.J. and Babus, S. (1999) Management of Intramedullary Spinal Cord Tumors: Review of 68 Patients. Neurology India, 47, 224-228.</mixed-citation></ref><ref id="scirp.113426-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Hanbali, F., Fourney, D.R., et al. (2002) Spinal Cord Ependymoma: Radical Surgical Resection and Outcome. Neurosurgery, 51, 1162-1174.  
https://doi.org/10.1097/00006123-200211000-00010</mixed-citation></ref><ref id="scirp.113426-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Sun, J.J., Wang, Z.Y., Li, Z.D. and Liu, B. (2009) Microsurgical Treatment and Functional Outcomes of Multi-Segment Intramedullary Spinal Cord Tumors. Journal of Clinical Neuroscience, 16, 666-671.  
https://doi.org/10.1016/j.jocn.2008.08.016</mixed-citation></ref><ref id="scirp.113426-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Berhouma, M., Bahri, K., Houissa, S., Zemmel, I., Khouja, N., Aouidj, L., Jemel, H. and Khaldi, M. (2009) Management of Intramedullary Spinal Cord Tumors: Surgical Considerations and Results in 45 Cases. Neurochirurgie, 55, 293-302.  
https://doi.org/10.1016/j.jocn.2008.08.016</mixed-citation></ref><ref id="scirp.113426-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Sandalcioglu, I.E., Gasser, T., Asgari, S., Lazorisak, A., Engelhorn, T., Egelhof, T., Stolke, D. and Wiedemayer, H. (2005) Functional Outcome after Surgical Treatment of Intramedullary Spinal Cord Tumors: Experience with 78 Patients. Spinal Cord, 43, 34-41. https://doi.org/10.1016/j.jocn.2008.08.016</mixed-citation></ref><ref id="scirp.113426-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Chamberlain, M.C. and Tredway, T.L. (2011) Adult Primary Intradural Spinal Cord Tumors: A Review. Current Neurology and Neuroscience Reports, 11, 320-328.  
https://doi.org/10.1007/s11910-011-0190-2</mixed-citation></ref></ref-list></back></article>